Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-02-21FDA Approved: CALCITRIOL — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves a generic calcitriol product from Sun Pharmaceutical Industries under an original ANDA, enabling another generic calcitriol opt…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Uraemic Toxins in Chronic Kidney Disease Paediatric Patients: Kinetic Analysis
A completed pediatric study in chronic kidney disease analyzed the kinetics of uraemic toxins. The study was sponsored by University Hospita…
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: Safety and Efficacy of ProQuad® in Children 6-24 Month Being Evaluated for Solid Organ Transplant [EARLY_Phase 1]
An early-phase 1 trial evaluated the safety and preliminary efficacy of ProQuad in children 6-24 months being evaluated for solid organ tran…
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: Ferumoxytol Enhanced Magnetic Resonance Angiography in Chronic Kidney Disease
Clinical trial evaluating ferumoxytol-enhanced magnetic resonance angiography in chronic kidney disease has completed.
-
FDA approval · 2019-02-08FDA Approved: SEVELAMER HYDROCHLORIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Sevelamer hydrochloride as a generic product under an original ANDA from Glenmark Pharmaceuticals Inc., USA.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-02-07Clinical Trial Update: A Study of LY2928057 in Hemodialysis Participants [Phase 1]
Phase 1 trial update for LY2928057 in adults with chronic renal insufficiency and chronic kidney disease; study completed with results poste…
-
CLINICAL_TRIALS trial_result · 2019-02-07Clinical Trial Update: Pentoxifylline Effect in Patients With Diabetic Nephropathy.(PENFOSIDINE STUDY) [Phase 4]
Phase 4 trial PENFOSIDINE is evaluating pentoxifylline in patients with diabetic nephropathy and chronic kidney disease stage 3-4; the curre…
-
CLINICAL_TRIALS trial_result · 2019-02-05Clinical Trial Update: Effectiveness of a Structured Intervention on the Development of Self-Care Behaviors With AVF in HD Patients [NA]
A completed clinical trial evaluated whether a structured intervention improves self-care behaviors in patients with an arteriovenous fistul…
-
CLINICAL_TRIALS trial_result · 2019-02-04Clinical Trial Update: Observational Study on the Incidence of NSF in Renal Impaired Patients Following Dotarem Administration
An observational study assessing the incidence of nephrogenic systemic fibrosis in patients with renal impairment after administration of Do…
-
CLINICAL_TRIALS research · 2019-02-04Clinical Trial Update: Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant Recipients [Phase 4]
A Phase 4 trial investigating anemia correction and native vitamin D supplementation in kidney transplant recipients was terminated.
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: Observational Study on CKD Treatment With a Ketosteril Supplemented Protein-restricted Diet (Keto-027-CNI)
An observational trial evaluating treatment of chronic kidney disease with a Ketosteril-supplemented, protein-restricted diet has completed.
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM) [Phase 4]
Phase 4 trial update evaluating the efficacy and safety of an everolimus-based regimen in renal transplant recipients (TRANSFORM).
-
CLINICAL_TRIALS trial_result · 2019-01-29Clinical Trial Update: Dialysis Performance of Different Dialyzer Membranes Using Different Coagulation Strategies [NA]
This clinical trial update notes the completion of a study comparing dialyzer membrane performance during hemodialysis using different coagu…
-
CLINICAL_TRIALS research · 2019-01-29Clinical Trial Update: Cessation of Dialysis Treatment in Reinbek and Geesthacht
This clinical trial update reports cessation of dialysis treatment in Reinbek and Geesthacht, linked to complications of renal dialysis and …
-
CLINICAL_TRIALS research · 2019-01-23Clinical Trial Update: Dermodialysis as Adjuvant Therapy in Renal Failure [NA]
Clinical trial update from Assiut University investigating Dermodialysis as adjuvant therapy for chronic kidney disease; the study status is…
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: A Study of LY3113593 in Healthy Participants and Participants With Chronic Kidney Disease Treated With Hemodialysis [Phase 1]
Phase 1 study of LY3113593 in healthy participants and in patients with chronic kidney disease on hemodialysis, with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: Effects of a Ketoacid Supplementation in Patients With Stage III to IV Renal Failure [Phase 3]
Phase 3 clinical trial evaluating the effects of ketoacid supplementation in patients with stage III to IV renal failure has completed.
-
CLINICAL_TRIALS trial_result · 2018-12-27Clinical Trial Update: A Study of The Effect of Altitude on Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) Dose Requirements in Participants With Chronic Renal Anemia in Pre-Dialysis or Dialysis [Phase 4]
A Phase 4 trial evaluated how altitude affects Mircera dosing requirements in adults with chronic renal anemia, including pre-dialysis and d…
-
CLINICAL_TRIALS trial_result · 2018-12-21Clinical Trial Update: Study of CS-3150 in Combination With ARB or ACE Inhibitor in Hypertensive Patients With Moderate Renal Impairment [Phase 3]
A Phase 3 study evaluating CS-3150 in combination with an ARB or ACE inhibitor for hypertension in patients with moderate renal impairment h…
-
FDA approval · 2018-12-19FDA Approved: VENOFER — Supplemental Application (Fresenius Medical Care Holdings, Inc.)
FDA approved a supplemental application for VENOFER (iron sucrose) submitted by Fresenius Medical Care Holdings, Inc.
-
FDA approval · 2018-11-20FDA Approved: CALCIUM ACETATE — Supplemental Application (Chartwell RX, LLC.)
FDA approved a supplemental application for Calcium Acetate from Chartwell RX, LLC.
-
FDA approval · 2018-11-08FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for FOSRENOL (lanthanum carbonate) submitted by Takeda, resulting in updated labeling for managing h…
-
FDA approval · 2018-11-08FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Fosrenol (lanthanum carbonate) from Takeda Pharmaceuticals America, Inc. The update pertains…
-
CLINICAL_TRIALS trial_result · 2018-11-06Clinical Trial Update: Safe Kidney Care Cohort Study
A completed clinical trial from the Safe Kidney Care cohort study registered at ClinicalTrials.gov with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-30Clinical Trial Update: TARGTEPO Treatment for Anemia in Chronic Kidney Disease (CKD) Patients and End-Stage Renal Disease (ESRD) [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating TARGTEPO for anemia in chronic kidney disease and end-stage renal disease; results were posted in 201…